AC Immune SA
Last updated September 27, 2026
Organization details
- Legal name
- AC Immune SA
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Switzerland
- Headquarters city
- 1015 Lausanne
- Headquarters country
- Switzerland
- Fiscal year end
- December
- Ticker symbol
- ACIU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001651625
Board of directors
-
Andrea Pfeifer · Director · Chief Executive OfficerSince 2026
-
Carl Howard June · DirectorSince 2026
-
Martin Zuegel · Director · Interim CEOSince 2026
-
Monika Buetler · DirectorSince 2026
-
Renee Aguiar-Lucander · DirectorSince 2026
-
Roy Ervin Twyman · DirectorSince 2026
Chief executives
Andrea Pfeifer
· Chief Executive Officer
Since March 2026
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $31,400
- 1 purchase by 1 insider
- Sold, last 12 months
- $27,900
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Roy Ervin Twyman Director | Grant or award | +16,568 | — | — |
| Jun 11, 2026 | Renee Aguiar-Lucander Director | Grant or award | +16,568 | — | — |
| Jun 11, 2026 | Martin Zuegel Director, Officer (Interim CEO) | Grant or award | +33,136 | — | — |
| Jun 11, 2026 | Monika Buetler Director | Grant or award | +17,751 | — | — |
| Jun 11, 2026 | Carl Howard June Director | Grant or award | +16,568 | — | — |
| May 15, 2026 | Andrea Pfeifer Director, Officer (Chief Executive Officer) | Open-market sale | −10,000 | $2.79 | $27,900 |
| Apr 15, 2026 | Andrea Pfeifer Director, Officer (Chief Executive Officer) | Open-market purchase | −10,000 | $3.14 | $31,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.